Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

L. Packer, Douglas; M. Prutkin, Jordan; S. Hellkamp, Anne; Brent Mitchell, L.; Bernstein, Robert; Wood, Freda; Boehmer, John; D. Carlson, Mark; P. Frantz, Robert; E. McNulty, Steve; G. Rogers, Joseph; Anderson, Jill; Johnson, George; Norine Walsh, Mary; E. Poole, Jeanne; B. Mark, Daniel; L. Lee, Kerry; H. Bardy, Gust

doi:10.1161/circulationaha.109.853689

Public

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure

Published in Circulation • Nov 16, 2009

Authors:

Douglas L. Packer

Jordan M. Prutkin

Anne S. Hellkamp

Abstract

BACKGROUND: The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) demonstrated that implantable cardioverter-defibrillator (ICD) therapy reduces all-cause mortality in patients with New York Heart Association class II/III heart failure and a left ventricular ejection fraction < or =35% on optim...

Subject

Medicine

Implantable cardioverter-defibrillator

Amiodarone

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!